Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): A cohort study

Lancet

Volumn 353, Issue 9165, 1999, Pages 1649-1652

  Schmidt, Maria Inês ^a,b   Duncan, Bruce B ^a,b   Sharrett, A Richey ^d   Lindberg, Gunnar ^e   Savage, Peter J ^d   Offenbacher, Steven ^c   Azambuja, Maria Inês ^a   Tracy, Russell P ^f   Heiss, Gerardo ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e Network for Pharmacoepidemiology Foundation   (Sweden)

^f UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; FIBRINOGEN; HAPTOGLOBIN; OROSOMUCOID; SERUM ALBUMIN; SIALIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; BODY BUILD; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL;

EID: 0033562455     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)01046-6     Document Type: Article

References (30)

1. Jarrett RJ, Shipley MJ. Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease: putative association via common antecedents - further evidence from the Whitehall Study. Diabetologia 1988; 31: 737-40.
2. Schmidt MI, Watson RL, Duncan BB, et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Metabolism 1996; 45: 699-706.
3. Stern MP. Diabetes and cardiovascular disease: the "common soil" hypothesis. Diabetes 1995; 44: 369-74.
4. Yudkin JS. Is insulin vasculotoxic? Diabetologia 1997; 40: S140-46.
5. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40: 1286-92.
6. Nilsson J, Jovinge S, Niemann A, Reneland R, Lithell H. Relation between plasma tumor necrosis factor-α and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Biol 1998; 18: 1199-202.
7. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-26.
8. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998; 41: 1241-48.
9. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 1989; 129: 687-702.
10. Nieto FJ, Szklo M, Folsom AR, Bock R, Mercun M, for the ARIC Investigators. Leukocyte count correlates in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 1992; 136: 525-37.
11. National Heart Lung and Blood Institute. Atherosclerosis Risk in Communities (ARIC) study protocol, manual 9. North Carolina: ARIC Study Coordinating Center, 1987: 1-87.
12. Chambless LE, McMahon RI, Wu KK, Folsom AR, Finch A, Shen Y-L. Short-term intraindividual variability in hemostasis factors, the ARIC Study. Ann Epidemiol 1992; 2: 723-33.
13. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-97.
14. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C, and the ARIC investigators. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991; 134: 250-56.
15. Jourdian GW, Dean L, Roseman S. The sialic acids. J Biol Chem 1971; 246: 430-35.
16. Kushner I, Mackiewicz A. The acute phase response: an overview. In: Mackiewicz A, Kushner I, Baumann H, eds. Acute phase proteins: molecular biology, biochemistry, and clinical applications. Boca Raton: CRC Press, 1993: 4-19.
17. Campos SP, Baumann H. Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes. Mol Cell Biol 1992; 12: 1789-92.
18. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 1997; 389: 610-14.
19. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996; 271: 665-68.
20. Van Der Poll T, Romijn JA, Endert E, Borm JJJ, Buller HR, Sauerwein HP. Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 1998; 24: E457-65.
21. Corbett J, Serup P, Bonner-Weir S, Nielsen JH. Beta-cell ontogeny: growth and death. Diabetologia 1997; 40: B27-32.
22. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. Diabetes 1995; 44: 863-70.
23. Loffreda S, Yang SQ, Lin HZ, et al. Leptin regulates proinflammatory immune responses. FASEB J 1998; 12: 57-65.
24. Girard J. Is leptin the link between obesity and insulin resistance? Diabetes Metab 1997; 23 (suppl 3): 16-24.
25. Lindberg G, Lundblad A, Gullberg B, Nilsson-Ehle P, Hanson BS. Serum total sialic acid and sialoprotein concentration in relation to coronary heart disease risk markers. Atherosclerosis 1993; 103: 123-29.
26. Sim E. Humoral factors. Oxford: IRL Press, 1993: 1-373.
27. Memon RA, Feingold KR, Grunfeld C. Cytokines and intermediary metabolism. In: Remick DG, Friedland JS, eds. Cytokines in health and disease, 2nd edn. New York: Marcel Dekker, 1997: 381-99.
28. Salhanick AI, Amatruda JM. Role of sialic acid in insulin action and the insulin resistance of diabetes mellitus. Am J Physiol 1988; 255: E173-79.
29. Matson CA, Wiater MF, Weigle DS. Leptin and the regulation of body adiposity. Diabetes Rev 1996; 4: 488-508.
30. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-15.